E. K. Yoo

发表

Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.

S. Lessin, A. Rook, E. K. Yoo, 2001, Journal of the American Academy of Dermatology.

Photopheresis: clinical applications and mechanism of action.

W. Macey, S. Lessin, A. Rook, 1999, The journal of investigative dermatology. Symposium proceedings.

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Interleukin-12 Therapy of Cutaneous T-Cell Lymphoma Induces Lesion Regression and Cytotoxic T-Cell Responses

G. Wood, S. Lessin, A. Rook, 2016 .

Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.

G. Wood, S. Lessin, A. Rook, 1999, Blood.

A revision of the Australian and tropical Indo-Pacific Tertiary and Recent species of Pisinna (= Estea) (Mollusca: Gastropoda: Rissoidae)

W. Ponder, E. K. Yoo, 1976 .

Early Carboniferous Gastropoda from the Tamworth Belt, New South Wales, Australia

E. K. Yoo, 1994 .

Early Carboniferous Mollusca from Gundy, Upper Hunter, New South Wales

E. K. Yoo, 1988 .

Kinetic Analysis of Apoptosis Induction in Human Cell Lines by UVA and 8‐MOP

F. Gasparro, B. Vowels, E. K. Yoo, 1996, Photochemistry and photobiology.

Photo recall effect in association with cefazolin.

J. Junkins-Hopkins, E. K. Yoo, A. Vanvoorhees, 2004, Cutis (New York, N.Y.).

Use of biological response modifiers in the treatment of cutaneous T-cell lymphoma.

D. Grossman, F. Fox, A. Rook, 1998, Current opinion in oncology.

Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action.

F. Gasparro, A. Rook, R. Elenitsas, 1996, The Journal of investigative dermatology.